Recent Trends in The Management of Viral Hepatitis: A Review

Viral hepatitis can cause significant morbidity and mortality, with the impact on health determined by the exact form of hepatitis, the geographical region of presentation, and the discovery and availability of new treatments, among other factors. Only a small percentage of cases result in acute liver failure that may require a transplant or even result in the patient's death; the majority of acute presenting types are self-limiting and may even go undetected. However, if they are not identified and treated appropriately, they can develop into chronic conditions like cirrhosis or hepatic carcinoma, as is the situation with the hepatitis B and C viruses. We now face a new scenario in the management of viral hepatitis, specifically hepatitis B and hepatitis C viruses, due to our growing understanding of the pathogenesis, the mechanisms of transmission, the availability of vaccinations, and the development of new, powerful medications in recent years. The World Health Organization has proposed the goal of eradicating the hepatitis C virus by 2030 due to the remarkable advancements in therapy. Making sure that these therapies are available to all of the more susceptible demographic groups where the various forms of viral hepatitis are highly prevalent and represent a niche that could prolong infection and impede its eradication is crucial to reaching this aim. As a result micro-elimination efforts are very important right now.